Peptonic Medical AB (publ) announced that the company has signed an exclusive agreement with Cetro Medical for distribution of VagiVital VS Pro and VagiVital AL to gynecology and obstetrics clinics in Sweden. The agreements means that Cetro Medical gets an exclusive right to sell VagiVital in the professional channel, i.e. to hospital and clinics. The agreement spans over three years with possible extension.

It further enables Peptonic to focus on its core business; clinically proven intimate self care according to the principle diagnose, treat, prevent. A user of Peptonics products shall be able to manage everything from identifying and treating the intimate health problem to preventive actions with products that prohibit the problems from returning. Some of the products are excellent for distribution to different healthcare units; VagiVital VS Pro is a customized version of VagiVital VS, which sell directly to consumers.

VagiVital VS Pro enables healthcare professionals to screen for bacterial vaginosis with a unique combination of precision and immediate results; VagiVital AL. Allows healthcare professionals to identify amniotic leakage with the same precision as in a gynecological examination, but without using sterile instruments and need for consulting rooms.